Alison Handley

Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

G. Bakris, Alfonso T. Perez, W. White, 2013, Journal of Human Hypertension.

Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring

G. Bakris, Alfonso T. Perez, W. White, 2011, Journal of clinical hypertension.

Comparison of long‐term safety of fixed‐dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide

W. Cushman, J. Neutel, E. Lloyd, 2017, Journal of clinical hypertension.

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension

G. Bakris, Alfonso T. Perez, W. White, 2017, Journal of clinical hypertension.

Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study

A. Roberts, E. Lloyd, A. Handley, 2016, Clinical and experimental hypertension.

Safety, Tolerability, and Efficacy of Azilsartan Medoxomil With or Without Chlorthalidone During and After 8 Months of Treatment for Hypertension

M. Kipnes, A. Roberts, E. Lloyd, 2015, Journal of clinical hypertension.

Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.

W. Cushman, G. Bakris, W. White, 2012, The American journal of medicine.